These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Distribution and characterization of enterostatin-like immunoreactivity in human cerebrospinal fluid. Imamura M; Sumar N; Hermon-Taylor J; Robertson HJ; Prasad C Peptides; 1998; 19(8):1385-91. PubMed ID: 9809653 [TBL] [Abstract][Full Text] [Related]
4. On the nature and distribution of enterostatin (Val-Asp-Pro-Asp-Arg)-like immunoreactivity in rat plasma. Imamura M; Debata C; Prasad C Peptides; 1999; 20(1):133-9. PubMed ID: 10098634 [TBL] [Abstract][Full Text] [Related]
5. Differential Regional Distribution of Enterostatin, an Appetite Inhibiting Peptide, in the Brains of Zucker and Sprague-Dawley Rats. Imamura M; Porter JR; Prasad C Nutr Neurosci; 1998; 1(6):449-53. PubMed ID: 27406552 [TBL] [Abstract][Full Text] [Related]
6. Identification of Enterostatin and the Relation between Lipase and Colipase in Various Species. Rippe C; Erlanson-Albertsson C Nutr Neurosci; 1998; 1(2):111-7. PubMed ID: 27406016 [TBL] [Abstract][Full Text] [Related]
7. Enterostatin (Val-Pro-Asp-Pro-Arg)-like immunoreactivity in rat urine: relationship to corticosterone output. Imamura M; Prasad A; Prasad C Life Sci; 1998; 63(16):1461-8. PubMed ID: 9952292 [TBL] [Abstract][Full Text] [Related]
8. Biology of enterostatin. II. Development of enzyme-linked immunosorbentassay (ELISA) for enterostatin (Val-Pro-Asp-Pro-Arg), the procolipase activation peptide. Mizuma H; Imamura M; Tiemann WE; Prasad C Biochem Biophys Res Commun; 1995 Oct; 215(1):227-34. PubMed ID: 7575595 [TBL] [Abstract][Full Text] [Related]
9. Fasting- and Feeding-associated Changes in Enterostatin (Val-Pro-Asp-Pro-Arg)-like Immunoreactivity in the Rat Brain. Imamura M; Prasad C Nutr Neurosci; 1998; 1(5):391-4. PubMed ID: 27406337 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of insulin release by intraduodenally infused enterostatin-VPDPR in rats. Mei J; Bouras M; Erlanson-Albertsson C Peptides; 1997; 18(5):651-5. PubMed ID: 9213357 [TBL] [Abstract][Full Text] [Related]
11. Effect of a satiating meal on the concentrations of procolipase propeptide in the serum and urine of normal and morbidly obese subjects. Bowyer RC; Rowston WM; Jehanli AM; Lacey JH; Hermon-Taylor J Gut; 1993 Nov; 34(11):1520-5. PubMed ID: 8244136 [TBL] [Abstract][Full Text] [Related]
12. Effects of enterostatin (Val-Pro-Asp-Pro-Arg) on fat intake and blood levels of glucose and insulin in rats. Koizumi M; Sato H; Seguro K; Ide H; Morinaga Y; Kimura S Methods Find Exp Clin Pharmacol; 2001 Jun; 23(5):235-9. PubMed ID: 11712642 [TBL] [Abstract][Full Text] [Related]
13. Corticosterone facilitation of inhibition of fat intake by enterostatin (Val-Pro-Asp-Pro-Arg). Mizuma H; Abadie J; Prasad C Peptides; 1994; 15(3):447-52. PubMed ID: 7937317 [TBL] [Abstract][Full Text] [Related]
14. The activation peptide of pancreatic procolipase decreases food intake in rats. Erlanson-Albertsson C; Larsson A Regul Pept; 1988 Sep; 22(4):325-31. PubMed ID: 3187077 [TBL] [Abstract][Full Text] [Related]
15. Endogenous Enterostatin, Proteases, and Dietary Fat Preference in Rats. Debata C; Prasad C Nutr Neurosci; 1998; 1(5):361-6. PubMed ID: 27406333 [TBL] [Abstract][Full Text] [Related]
16. Enterostatin reduces serum cholesterol levels by way of a CCK(1) receptor-dependent mechanism. Takenaka Y; Shimano T; Mori T; Hou IC; Ohinata K; Yoshikawa M Peptides; 2008 Dec; 29(12):2175-8. PubMed ID: 18824202 [TBL] [Abstract][Full Text] [Related]